2GIU
Human estrogen receptor beta ligand-binding domain in complex with compound 45
Summary for 2GIU
Entry DOI | 10.2210/pdb2giu/pdb |
Descriptor | Estrogen receptor beta, (9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one (3 entities in total) |
Functional Keywords | nuclear receptor, transcription factor, er-beta, agonist, transcription regulator |
Biological source | Homo sapiens (human) |
Cellular location | Nucleus : Q92731 |
Total number of polymer chains | 1 |
Total formula weight | 27557.53 |
Authors | Fitzgerald, P.M.D.,Sharma, N. (deposition date: 2006-03-29, release date: 2006-10-10, Last modification date: 2024-04-03) |
Primary citation | Wilkening, R.R.,Ratcliffe, R.W.,Tynebor, E.C.,Wildonger, K.J.,Fried, A.K.,Hammond, M.L.,Mosley, R.T.,Fitzgerald, P.M.D.,Sharma, N.,McKeever, B.M.,Nilsson, S.,Carlquist, M.,Thorsell, A.,Locco, L.,Katz, R.,Frisch, K.,Birzin, E.T.,Wilkinson, H.A.,Mitra, S.,Cai, S.,Hayes, E.C.,Schaeffer, J.M.,Rohrer, S.P. The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands. Bioorg.Med.Chem.Lett., 16:3489-3494, 2006 Cited by PubMed Abstract: Synthesis and derivatization of a series of substituted tetrahydrofluorenone analogs giving potent, ERbeta subtype selective ligands are described. Several analogs possessing ERbeta binding affinities comparable to 17beta-estradiol but with greater than 75-fold selectivity over ERalpha are reported. PubMed: 16632357DOI: 10.1016/j.bmcl.2006.03.098 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.2 Å) |
Structure validation
Download full validation report